aminocamptothecin
Term · Oncology and biomedicine · MLC-T-ONC-000453
An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors.
A water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agent's antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity.
| Identifier | MLC-T-ONC-000453 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 9-AC |
| Synonyms | 9-amino-camptothecin; 9-aminocamptothecin; 9-amino-CPT |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-000453",
"term": "aminocamptothecin",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors.",
"A water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agent's antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity."
],
"abbreviation": "9-AC",
"synonyms": [
"9-amino-camptothecin",
"9-aminocamptothecin",
"9-amino-CPT"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aminocamptothecin/"
}
Record 971 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.